Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice

被引:23
作者
Haston, CK
Corey, M
Tsui, LC
机构
[1] Hosp Sick Children, Genet Program, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Program Genomic Biol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Inst Res, Populat Hlth Sci Program, Toronto, ON, Canada
[4] Univ Toronto, Dept Med & Mol Genet, Toronto, ON, Canada
[5] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
关键词
D O I
10.1007/s00335-002-2195-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the poorly understood clinical manifestations of cystic fibrosis (CF) is low body weight. Mice in which the CF causative gene, cystic fibrosis transmembrane conductance regulator (Cftr), has been knocked out reflect this as they are smaller than age-matched littermates. The variable weight of F-2 Cftr -/- (CF) mice derived from a cross between congenic C57BL/6J and BALB/cJ Cftr heterozygotic mice permits the mapping of modifiers of this cystic fibrosis phenotype. In this report, quantitative trait loci (QTL) mapping was used to identify the chromosomal locations of genes that contribute to the body weight of 12-week-old F-2 CF mice. Five loci of CF body weight were detected with four of the five acting in a sex-specific manner. Significant linkage of the phenotype to a region of Chromosome (Chr) 13 from D13Mit179 to D13Mit254 (LOD = 4.2) was established in female mice; and suggestive loci on Chrs 7 and 10 were identified. The weights of F-2 male CF mice were suggestively linked to regions of Chrs 1 and 6, and to the same locus on Chr 7 as in female mice. The suggestive loci did not influence the weight of the limited set of control mice and thus are presumed to be CF specific in their effects. Further study of these putative CF body weight modifiers may provide insight on the pathogenesis of cystic fibrosis.
引用
收藏
页码:614 / 618
页数:5
相关论文
共 37 条
[1]  
[Anonymous], 1998, Genetics and Analysis of Quantitative Traits (Sinauer)
[2]   The ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells [J].
Bhura-Bandali, FN ;
Suh, M ;
Man, SFP ;
Clandinin, MT .
JOURNAL OF NUTRITION, 2000, 130 (12) :2870-2875
[3]   The insulin-like growth factor-I system and hormone replacement therapy [J].
Cardim, HJP ;
Lopes, CMC ;
Giannella-Neto, D ;
da Fonseca, AM ;
Pinotti, JA .
FERTILITY AND STERILITY, 2001, 75 (02) :282-287
[4]   The human obesity gene map:: The 1999 update [J].
Chagnon, YC ;
Pérusse, L ;
Weisnagel, SJ ;
Rankinen, T ;
Bouchard, C .
OBESITY RESEARCH, 2000, 8 (01) :89-117
[5]  
CHURCHILL GA, 1994, GENETICS, V138, P963
[6]  
Davidson D J, 2001, Trends Genet, V17, pS29, DOI 10.1016/S0168-9525(01)02452-0
[7]   Cystic fibrosis [J].
Davis, PB ;
Drumm, M ;
Konstan, MW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) :1229-1256
[8]  
de Villena FPM, 2000, GENETICS, V154, P351
[9]   A comprehensive genetic map of the mouse genome [J].
Dietrich, WF ;
Miller, J ;
Steen, R ;
Merchant, MA ;
DamronBoles, D ;
Husain, Z ;
Dredge, R ;
Daly, MJ ;
Ingalls, KA ;
OConnor, TJ ;
Evans, CA ;
DeAngelis, MM ;
Levinson, DM ;
Kruglyak, L ;
Goodman, N ;
Copeland, NG ;
Jenkins, NA ;
Hawkins, TL ;
Stein, L ;
Page, DC ;
Lander, ES .
NATURE, 1996, 380 (6570) :149-152
[10]   Effect of the genetic background on the reproduction of leptin-deficient obese mice [J].
Ewart-Toland, A ;
Mounzih, K ;
Qiu, J ;
Chehab, FF .
ENDOCRINOLOGY, 1999, 140 (02) :732-738